logo
  

Barrick Gold FY Profit Down

Barrick Gold Corp. (GOLD, ABX.TO) reported that its net earnings attributable to the equity holders of the company for fiscal year 2020 declined to $2.32 billion from $3.97 billion in the prior year. On a per share basis, net income was $1.31 compared to $2.26 in the previous year.

Adjusted net income was $1.15 compared to $0.51 last year. Analysts polled by Thomson Reuters expected the company to report earnings of $1.14 per share for fiscal year 2020. Analysts' estimates typically exclude special items.

Revenues for the year rose to $12.60 billion from $9.72 billion in the prior year. Analysts expected revenues of $12.5 billion for fiscal year 2020.

Barrick Gold plans to propose to shareholders a return of capital distribution of approximately $0.42 per share. It has also declared a dividend for the fourth quarter of 2020 of $0.09 per share, payable on March 15, 2021, to shareholders of record at the close of business on March 1, 2021.

The return of capital will be proposed to shareholders at its Annual and Special Meeting on May 4, 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Health insurer Humana Inc. reported Wednesday a net loss for the fourth quarter that slightly widened from last year, hurt primarily by charges associated with productivity initiatives, despite 6.6 percent revenue growth. Adjusted earnings for the quarter topped analysts' expectations, while quarterly revenues missed it by a whisker. South Plainfield, New Jersey-based Two Rivers Coffee is recalling its peanut butter single serve hot chocolate pods citing an undeclared peanut allergen, the U.S. Food Drug Administration said. The recall involves peanut butter single serve hot chocolate pods distributed as "Brooklyn Bean Peanut Butter Cup Hot Cocoa", "Pingo Peanut Butter Cookie Hot Chocolate" and ... Shares of Novartis AG were losing around 2 percent in the early morning trading in Switzerland after the drug major reported Wednesday sharply lower profit in its fourth quarter with weak sales as well as the absence of prior year's hefty Roche income. Adjusted earnings, however, topped market estimates, while top line missed their view. Further, the company announced higher dividend...
RELATED NEWS
Follow RTT